What is the U.S. liquid biopsy market size in 2026?

The U.S. Liquid biopsy market is projected to reach US$2.1 billion in 2026.

What drives the U.S. liquid biopsy market?

The U.S. liquid biopsy market is driven by the rising cancer prevalence and increasing demand for non-invasive, early cancer detection and precision oncology diagnostics.

What is the growth rate for the U.S. liquid biopsy market?

The U.S. liquid biopsy market is expected to grow at a CAGR of 13.6% from 2026 to 2033.

What are the key market opportunities?

Key market opportunities in the U.S. liquid biopsy market include expansion into population-level cancer screening programs and integration with immunotherapy monitoring to guide personalized treatment decisions.

Who are the key players in the U.S. liquid biopsy market?

ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Epigenomics AG, Exact Sciences Corporation, and F. Hoffmann-La Roche AG are the leading players.

Table of Content - U.S. Liquid Biopsy Market Size, Share, and Growth Forecast, 2026

Executive Summary
1. U.S. Liquid Biopsy Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. COVID-19 Impact Analysis
4. Forecast Factors – Relevance and Impact
Value Added Insights
1. Value Chain Analysis
2. Night Contact Lens Adoption / Usage Analysis
3. Key Market Players
4. Key Promotional Strategies, By Key Players
5. Regulatory Landscape
6. PESTLE Analysis
7. Porter’s Five Force Analysis
Price Trend Analysis, 2025
1. Key Highlights
2. Pricing and Volume (Unit) Analysis, ByBiomarker
3. Regional Prices and Product Preferences
U.S. Liquid Biopsy Market Outlook
1. Key Highlights
  1. Market Volume (Unit) Projections
  2. Market Size (US$ Bn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2024
  2. Market Size (US$ Bn) Analysis and Forecast, 2025–2033
3. U.S. Liquid Biopsy Market Outlook: Product Type
  1. Historical Market Size (US$ Bn) Analysis, By Product Type, 2020-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025–2033
    1. Kits & Reagents
    2. Instruments/Devices
    3. Software & Bioinformatics Tools
    4. Services
    5. Others
  3. Market Attractiveness Analysis: Product Type
4. U.S. Liquid Biopsy Market Outlook: By Biomarker
  1. Historical Market Size (US$ Bn) Analysis, By Biomarker, 2020-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Biomarker, 2025–2033
    1. Cell-free DNA (cfDNA)
    2. Cell-Free RNA
    3. Circulating Tumor Cells (CTCs)
    4. Exosomes and Extracellular Vesicles
    5. Circulating Tumor DNA (ctDNA)
  3. Market Attractiveness Analysis: By Biomarker
5. U.S. Liquid Biopsy Market Outlook: By Indication
  1. Historical Market Size (US$ Bn) Analysis, By Indication, 2020-2024
  2. Market Size (US$ Bn) and Forecast Analysis, By Indication, 2025–2033
    1. Lung Cancer
    2. Breast Cancer
    3. Colorectal Cancer
    4. Prostate Cancer
    5. Ovarian Cancer
  3. Market Attractiveness Analysis: By Indication
U.S. Liquid Biopsy Market Outlook: Zone
1. Historical Market Size (US$ Bn) Analysis, By Zone, 2020-2024
2. Market Size (US$ Bn) Analysis and Forecast, By Zone, 2025–2033
  1. West U.S.
  2. Midwest U.S.
  3. Southwest U.S.
  4. Southeast U.S.
  5. Northeast U.S.
3. Market Attractiveness Analysis: Zone
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping by Market
  2. Competition Dashboard
3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
  1. ANGLE plc, Biocept Inc.
    1. Overview
    2. Segments and Distribution Channels
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Bio-Rad Laboratories Inc.
  3. Epigenomics AG
  4. Exact Sciences Corporation
  5. F. Hoffmann-La Roche AG
  6. Guardant Health Inc.
  7. Illumina Inc.
  8. MDxHealth SA
  9. Menarini Silicon Biosystems
  10. QIAGEN N.V.
  11. Thermo Fisher Scientific Inc.
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

U.S. Liquid Biopsy Market Size, Share, and Growth Forecast, 2026 – 2033

U.S. Liquid Biopsy Market by Product Type (Kits & Reagents, Instruments/Devices, Others), Biomarker (Cell-free DNA (cfDNA), Cell-Free RNA, Circulating Tumor Cells (CTCs), Others), Indication (Lung Cancer, Breast Cancer, Others), and Zone Analysis for 2026 – 2033

Quick Links

Our Partners

Secure Payments Through